Zymeworks (ZYME) Gains Fresh Backing On Trial Data And Roche Deal
Zymeworks (ZYME) has drawn fresh attention after two October announcements: new Phase 1 data for its antibody drug conjugate ZW191 in ovarian cancer, and a wide-ranging licensing d…
标签：CANCER
包含 “CANCER” 的相关新闻
BioNTech (BNTX) Enters First Global Phase 3 Trial For New Breast Cancer Combo
BioNTech (NasdaqGS:BNTX) and Gilead Sciences announced a clinical trial collaboration to test a novel first-line treatment approach in metastatic triple-negative breast cancer. The…
GRAIL, Inc. (GRAL) Surged After FDA Panel Backed Its Cancer Detection Test: Here’s Why
Mott Capital Management, an investment research and management firm, released its "Thematic Growth Strategy" Q3 2026 investor letter. A copy of the letter can be downloaded here. T…
Is Cancer And HIV Trial Wins Altering The Investment Case For Merck (MRK)?
Merck reported fresh Phase 3 wins in oncology and HIV, detailed progress on its personalized mRNA cancer vaccine with Moderna, secured new European approval for KEYTRUDA plus Padce…
Rocket One's Hoth Therapeutics Reports Strong HT-001 Efficacy Results, Ends Phase 2a Early and Plans to Pursue Phase 3 to Bring Treatment to Cancer Patients
Positive interim findings drive early trial conclusion; Hoth prepares to seek FDA alignment on a potential pivotal study for cancer treatment–related skin toxicity HOBOKEN, N.J., N…
Ropeg Advances Essential Thrombocythemia Treatment Worldwide as European Patients Await Access
TAIPEI, Taiwan, November 03, 2026--(BUSINESS WIRE)--PharmaEssentia's blood cancer treatment, ropeginterferon alfa-2b (Ropeg), has secured approvals for essential thrombocythemia (E…
OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer
ROCKVILLE, Md., Nov. 2, 2026 /PRNewswire/ -- OncoC4, Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and immunological diseases, today a…
How the next major AI breakthrough could cure cancer: You.com CEO
You.com and Recursive CEO, Richard Socher, breaks down to Yahoo Finance Executive EditorBrian Sozzi how superintelligent AI is poised to make biology programmable, leading to massi…
Eli Lilly (LLY) Unveils Diabetes Cancer And Colitis Trial Wins Across Its Pipeline
Eli Lilly (NYSE: LLY) reports strong Phase 3 data for retatrutide in type 2 diabetes, including a head-to-head trial versus Ozempic. The company announces positive Phase 1 results…
Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial
Novartis (SWX:NOVN) reported new trial data showing Votrient plus Roche's Avastin improved overall survival in certain advanced kidney cancer patients. The combination delivered ov…